MKI67 and meningioma: The Ki-67/MIB-1 monoclonal antibody is a marker of tumor proliferative activity correlating with histopathological malignancy grade [38] and is widely used in pathologic grading of meningiomas, affecting both diagnosis and prognosis [38].